Both CD4⁺ and CD8⁺ T cells, as well as antibody, are known to be important in sporozoite immunity. Data from animal studies suggest that cytokines, in particular γ-interferon and interleukin-6, are involved. The interplay of these various factors and their importance in vaccine development has, however, not yet been elucidated. In this study, we have studied cellular and humoral responses of individuals naturally exposed to malaria in a highly endemic region of Papua New Guinea to the circumsporozoite protein of Plasmodium falciparum, a prime vaccine candidate antigen. A paucity of any CD4⁺ lymphoproliferative response to this protein by Papua New Guineans was notable which parallels our recent observation of a paucity of CD8⁺ T cell respon...
Conserved and variant regions of two blood stage vaccine candidate antigens of Plasmodium fakciparum...
T-cell responses directed against the circumsporozoite protein (CS) of Plasmodium falciparum can med...
The candidate malaria vaccine RTS,S/AS01E provides significant but partial protection from clinical ...
Cytotoxic T lymphocytes (CTL) specific for epitope(s) within the circumsporozoite (CS) protein of ma...
To assess natural immunity against the circumsporozoite (CS) protein and the synthetic vaccine SPf66...
Using a complete series of overlapping peptides, we have identified the T cell epitopes of a malaria...
Liver-stage antigen 1 (LSA1) is one of several pre-erythrocytic antigens considered for inclusion in...
Many human T-cell responses specific for epitopes in Plasmodium falciparum have been described, but ...
The impact of duration and intensity of sporozoite challenge on the in vitro cell immune response to...
Natural immunity to malaria is characterized by low level CD4 T cell reactivity detected by either l...
The merozoite surface protein-1 (MSP1) is the most studied malaria blood-stage vaccine candidate. Ly...
Several cellular and humoral mechanisms probably play a role in natural immunity to Plasmodium falci...
The role of antigen specific CD8+ T-lymphocytes in mediating protection against sporozoite-induced m...
Protective immunity to malaria has been achieved in human volunteers utilizing the pre-erythrocytic ...
Centers for Disease Control.Division of Parasitic Diseases, National Center for Infectious Diseases....
Conserved and variant regions of two blood stage vaccine candidate antigens of Plasmodium fakciparum...
T-cell responses directed against the circumsporozoite protein (CS) of Plasmodium falciparum can med...
The candidate malaria vaccine RTS,S/AS01E provides significant but partial protection from clinical ...
Cytotoxic T lymphocytes (CTL) specific for epitope(s) within the circumsporozoite (CS) protein of ma...
To assess natural immunity against the circumsporozoite (CS) protein and the synthetic vaccine SPf66...
Using a complete series of overlapping peptides, we have identified the T cell epitopes of a malaria...
Liver-stage antigen 1 (LSA1) is one of several pre-erythrocytic antigens considered for inclusion in...
Many human T-cell responses specific for epitopes in Plasmodium falciparum have been described, but ...
The impact of duration and intensity of sporozoite challenge on the in vitro cell immune response to...
Natural immunity to malaria is characterized by low level CD4 T cell reactivity detected by either l...
The merozoite surface protein-1 (MSP1) is the most studied malaria blood-stage vaccine candidate. Ly...
Several cellular and humoral mechanisms probably play a role in natural immunity to Plasmodium falci...
The role of antigen specific CD8+ T-lymphocytes in mediating protection against sporozoite-induced m...
Protective immunity to malaria has been achieved in human volunteers utilizing the pre-erythrocytic ...
Centers for Disease Control.Division of Parasitic Diseases, National Center for Infectious Diseases....
Conserved and variant regions of two blood stage vaccine candidate antigens of Plasmodium fakciparum...
T-cell responses directed against the circumsporozoite protein (CS) of Plasmodium falciparum can med...
The candidate malaria vaccine RTS,S/AS01E provides significant but partial protection from clinical ...